COM
CATALYST PHARMACEUTICALS INC
CATALYST PHARMACEUTICALS INC
Holdings as of 2026-06-30Filed 2026-08-14Updated 2026-10-22
View original evidence ↗Consensus3.5/100→ 0Current quarter score · 2026 Q2
Investors holding1
New positions1
Increased0
Decreased0
Exited1
Holdings by investor
↓ CSV↔ Scroll table
| Investor | Portfolio weight | Shares | Shares Δ | Change | Filed | Evidence |
|---|---|---|---|---|---|---|
| Soros Fund ManagementSoros Fund Management | 0.18%+0.2 pp | 344,593 | — | New | 2026-08-14 | SEC filing |
| Terry Smith / FundsmithFundsmith | 0.00%-0.2 pp | 0 | -100.0% | Exited | 2026-08-14 | SEC filing |
Ownership over time
All 20 quarters
| Quarter | Investors holding |
|---|---|
| 2026 Q2 | 1 |
| 2026 Q1 | 1 |
| 2025 Q4 | 1 |
| 2025 Q3 | 1 |
| 2025 Q2 | 1 |
| 2025 Q1 | 1 |
| 2024 Q4 | 0 |
| 2024 Q3 | 0 |
| 2024 Q2 | 0 |
| 2024 Q1 | 0 |
| 2023 Q4 | 0 |
| 2023 Q3 | 0 |
| 2023 Q2 | 0 |
| 2023 Q1 | 0 |
| 2022 Q4 | 0 |
| 2022 Q3 | 0 |
| 2022 Q2 | 0 |
| 2022 Q1 | 0 |
| 2021 Q4 | 0 |
| 2021 Q3 | 0 |
Inside the Consensus Score
breadth1.9 / 30
conviction0.0 / 20
activity0.6 / 20
trend0.5 / 15
persistence0.5 / 15
Original sources
Public commentary is shown only when a dated, verified original is available.
Soros Fund ManagementOfficial SEC filing
FundsmithOfficial SEC filing
Advanced · SEC data & downloads
CUSIP 14888U101 · COM
Original information table · XML/data
Original information table · XML/data
Soros Fund Management · 13F-HR · SEC filing · TXT
Fundsmith · 13F-HR · SEC filing · TXT
Download full history CSV · all candidate groups